Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program

Go back to Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program
(NASDAQ: ACHV) Delayed: 5.52 --0 (-0%)
Previous Close $5.52    52 Week High
Open $5.52    52 Week Low
Day High $5.97    P/E N/A 
Day Low $5.49    EPS
Volume 1,172,808